DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)

NCT07274462 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Microvascular Inflammation - MVI in Kindey Transplant Recipients

Interventions

DRUG: DARATUMUMAB (DARZALEX®)
OTHER: Observation (Standard Care)

Sponsor

University Hospital, Martin